{"id":19883,"date":"2014-04-21T08:49:51","date_gmt":"2014-04-21T12:49:51","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=19883"},"modified":"2014-04-21T08:49:51","modified_gmt":"2014-04-21T12:49:51","slug":"zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883","title":{"rendered":"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0<b>Zalicus Inc (NASDAQ:ZLCS) <\/b>will merge with Epirus Biopharmaceuticals and become a subsidiary of Epirus that will work under the management of Epirus. The merged entity will trade at Nasdaq as a public listed company that focus only in the bio similar space.<\/p>\n<p style=\"text-align: justify;\"><b>Deal transaction<\/b><\/p>\n<p style=\"text-align: justify;\">Zalicus will offer the following alternatives from the transaction to enhance its cash position.<\/p>\n<ul style=\"text-align: justify;\">\n<li>If Zalicus\u2019 closing net cash is equal or more than $12 million \u2013 Existing Zalicus stockholders will own ~19%, and Epirus stockholders will own ~81%.<\/li>\n<li>If Zalicus\u2019 closing net cash is equal or more than $9 million, but less than $12 million \u2013 Existing Zalicus stockholders will own ~17%, and Epirus stockholders will own ~83%.<\/li>\n<li>If Zalicus\u2019 closing net cash is equal or less than $9 million \u2013 Existing Zalicus stockholders will own ~14%, and Epirus stockholders will own ~86%.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">The shareholders\u2019 will benefit from the deal depending on Zalicus Inc (NASDAQ:ZLCS)\u2019s closing cash position that are likely to close in 2014.<\/p>\n<p style=\"text-align: justify;\"><b>New business<\/b><\/p>\n<p style=\"text-align: justify;\">The new Company will focus to develop Epirus\u2019s pipeline biosimilar products. It includes biosimilar of most popular medicines such as Remicade (BOW015), Humira (BOW050) and Avastin (BOW030). These products are well known monoclonal antibodies (MoA) and are used to treat different diseases.<\/p>\n<p style=\"text-align: justify;\"><b>Potential market<\/b><\/p>\n<p style=\"text-align: justify;\">Janssen\u2019s Remicade and AbbVie\u2019s Humira are two leading product primarily used as first-line therapy against autoimmune diseases. It includes popular diseases like rheumatoid arthritis, ulcerative colitis and Crohn&#8217;s disease. Both the medicines continue to drive the treatment market due to its premium price and limited alternatives for biologic products. Similarly, Roche\u2019s Avastin is a MoA mainly used to treat a variety of cancers including lungs, breast, kidney, ovarian and colorectal.<\/p>\n<p style=\"text-align: justify;\">Cheaper generics are available to treat autoimmune diseases; however, they are unable to create demand due to their efficiency. Therefore, biosimilars expect to fulfill the demand as a result of high efficiency and cheaper compared to available therapies. Biosimilars are the products mainly derived from the same source like other biologics (monoclonal antibodies) with limited trial process.<\/p>\n<p style=\"text-align: justify;\"><b>Conclusion<\/b><\/p>\n<p style=\"text-align: justify;\">Zalicus Inc (NASDAQ:ZLCS) believes that the combined entity will have a strong portfolio of biosimilars pipeline that has a solid market potential to treat rheumatoid arthritis patients. The merged company with strong management will make create considerable worth for shareholders.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0Zalicus Inc (NASDAQ:ZLCS) will merge with Epirus Biopharmaceuticals and become a subsidiary of Epirus that will work under the management of [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":19884,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[6032,6031],"stock_ticker":[],"class_list":["post-19883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqzlcs","tag-zalicus-inc-nasdaqzlcs","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business  - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business  - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0Zalicus Inc (NASDAQ:ZLCS) will merge with Epirus Biopharmaceuticals and become a subsidiary of Epirus that will work under the management of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-21T12:49:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"250\" \/>\n\t<meta property=\"og:image:height\" content=\"202\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Brendan Byrne\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brendan Byrne\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883\"},\"author\":{\"name\":\"Brendan Byrne\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\"},\"headline\":\"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business\",\"datePublished\":\"2014-04-21T12:49:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883\"},\"wordCount\":380,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg\",\"keywords\":[\"NASDAQ:ZLCS\",\"Zalicus Inc. (NASDAQ:ZLCS)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883\",\"name\":\"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg\",\"datePublished\":\"2014-04-21T12:49:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg\",\"width\":250,\"height\":202},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\",\"name\":\"Brendan Byrne\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"caption\":\"Brendan Byrne\"},\"description\":\"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business  - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883","og_locale":"en_US","og_type":"article","og_title":"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business  - Wall Street PR","og_description":"Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0Zalicus Inc (NASDAQ:ZLCS) will merge with Epirus Biopharmaceuticals and become a subsidiary of Epirus that will work under the management of [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-04-21T12:49:51+00:00","og_image":[{"width":250,"height":202,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg","type":"image\/jpeg"}],"author":"Brendan Byrne","twitter_misc":{"Written by":"Brendan Byrne","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883"},"author":{"name":"Brendan Byrne","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511"},"headline":"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business","datePublished":"2014-04-21T12:49:51+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883"},"wordCount":380,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg","keywords":["NASDAQ:ZLCS","Zalicus Inc. (NASDAQ:ZLCS)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883","url":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883","name":"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg","datePublished":"2014-04-21T12:49:51+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/ZALICUS-INC.jpg","width":250,"height":202},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/zalicus-inc-nasdaqzlcs-merge-to-enter-profitable-business-19883#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Zalicus Inc (NASDAQ:ZLCS): Merge To Enter Profitable Business"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511","name":"Brendan Byrne","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","caption":"Brendan Byrne"},"description":"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/19883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=19883"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/19883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/19884"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=19883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=19883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=19883"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=19883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}